Nutriband Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nutriband Inc. on August 7, 2018, covering events occurring on August 2, 2018. The company is incorporated in Nevada and maintains its principal executive offices in Orlando, Florida.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance updates rather than financial performance data.
Material Changes
The primary material change disclosed is the appointment of Larry Dillaha, MD, as the Company's Chief Medical Officer and as a member of its Pharmaceutical Advisory Board.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. It serves solely as a Regulation FD disclosure regarding the executive appointment. The press release detailing this appointment is included as Exhibit 99.1.
Investor Verification Checklist
- Verify the professional background and qualifications of the newly appointed Chief Medical Officer, Larry Dillaha, MD.
- Confirm the specific responsibilities and scope of the Pharmaceutical Advisory Board.
- Review the full text of the press release (Exhibit 99.1) for additional context on the appointment.
- Note that this filing does not contain updated financial statements or operational metrics.